Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylation pathway enzymes are a group of enzymes responsible for catalyzing the transfer of methyl groups (–CH₃) to various substrates, including DNA, RNA, proteins, and small molecules. This process is fundamental in regulating gene expression, epigenetic modifications, protein function, and cellular metabolism. Key enzymes include DNA methyltransferases (DNMTs), histone methyltransferases, methionine adenosyltransferase (MAT), S-adenosylhomocysteine hydrolase (SAHH), and methionine synthase. Dysregulation is linked to cancer and developmental disorders.
Inhibition or modulation of enzymatic activity related to methyl group transfer.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylation Pathway Enzymes (N/A).